Novartis AG (CHF)
NOVN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryDrug Manufacturers - Major
Day Range84.91 | 85.55
52-Wk Range71.69 | 94.40
Last Close85.51
Mkt Cap (m)195,971.82
Dividend yield3.33%
ISINCH0012005267
Volume4,779,506
Exchange VenueSWX

Company Profile

Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.

Key Information
Price/Earning29.14
Price/Book3.83
Price/Sales3.73
P/CF15.07
Rev Growth (3 year avg)1.81
EPS Growth (3 year avg)-0.10
Operating Margin % 15.37
Net Margin %23.72
Return on Equity16.51
Debt/Equity0.41

Legal Documents

Prospectus
en 15/02/2017
Annual Report
en 31/12/2018

Financials

Income Statement
CHF201320142015201620172018
Revenue (m)58,83153,63450,38749,43650,13553,166
Operating Income (m)10,91011,0898,9778,2688,6298,169
Net Income (m)9,17510,21017,7836,7127,70312,611
Basic EPS3.764.217.402.823.285.44
Avg. Diluted Shares Outstanding (m)2,4792,4702,4382,4002,3712,344
Balance Sheet
CHF201320142015201620172018
Current Assets (m)30,54237,56122,84524,93128,20835,563
Non Current Assets (m)95,71287,826108,711105,193104,871110,000
Total Assets (m)126,254125,387131,556130,124133,079145,563
Current Liabilities (m)26,36826,97323,70822,20923,40329,607
Total Liabilities (m)------
Total Equity (m)74,34370,76677,04674,83274,16878,614
Cash Flows
CHF201320142015201620172018
Operating Cash Flows (m)13,17413,89711,89711,47512,62114,272
Capital Expenditure (m)-3,571-3,404-3,505-2,879-2,746-3,355
Figures are quoted in CHF unless stated otherwise
-0.37 (-0.43%)
85.14
Last Price